Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 effect on PVR in Heart Failure
NCT02129179Phase 1Completed
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Glucagon-like peptide 1 in heart failure (HF). Primary endpoint: Change in Pulmonary Vascular Resistance at 30 minutes. Started Jun 2014; status: completed.
02
Drugs
Glucagon-like peptide 1
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02129179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02129179.